• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

2

CATEGORIES

  • 1
  • 1

PRICE

0
0
0
2

PUBLISHED

0
0
0
2

PRODUCT TYPE

2

Search "Osteoarthritis Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017" returned 2 results.

PRODUCT TITLE

Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014

GBI Research, the leading business intelligence provider, has released its latest report, “Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry...

January 2012
FROM

Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth

GBI Research, the leading business intelligence provider, has released its latest research, “Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch...

December 2012
FROM
Loading Indicator